<DOC>
	<DOCNO>NCT00633048</DOCNO>
	<brief_summary>This first time NSA-789 , new compound develop schizophrenia , give human . Each healthy subject receive single dose , except 8 subject receive 2 dos -- one dose fast condition one dose eat food .</brief_summary>
	<brief_title>Study Evaluating Safety Tolerability NSA-789</brief_title>
	<detailed_description />
	<criteria>Inclusion : Healthy men woman 18 50 year old . Women must nonchildbearing potential ( able child ) . Must normal body weight .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>ascend single-dose study</keyword>
	<keyword>healthy subject</keyword>
</DOC>